JP2007514732A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514732A5
JP2007514732A5 JP2006544590A JP2006544590A JP2007514732A5 JP 2007514732 A5 JP2007514732 A5 JP 2007514732A5 JP 2006544590 A JP2006544590 A JP 2006544590A JP 2006544590 A JP2006544590 A JP 2006544590A JP 2007514732 A5 JP2007514732 A5 JP 2007514732A5
Authority
JP
Japan
Prior art keywords
carbon
pharmaceutical composition
compound
teo
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006544590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514732A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/004163 external-priority patent/WO2005060341A2/en
Publication of JP2007514732A publication Critical patent/JP2007514732A/ja
Publication of JP2007514732A5 publication Critical patent/JP2007514732A5/ja
Pending legal-status Critical Current

Links

JP2006544590A 2003-12-18 2004-12-15 神経変性過程の予防及び治療のためのテルル誘導体 Pending JP2007514732A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53049003P 2003-12-18 2003-12-18
PCT/IB2004/004163 WO2005060341A2 (en) 2003-12-18 2004-12-15 Tellurium derivatives for prevention and treatment of neurodegenerative processes

Publications (2)

Publication Number Publication Date
JP2007514732A JP2007514732A (ja) 2007-06-07
JP2007514732A5 true JP2007514732A5 (https=) 2008-01-10

Family

ID=34710166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006544590A Pending JP2007514732A (ja) 2003-12-18 2004-12-15 神経変性過程の予防及び治療のためのテルル誘導体

Country Status (7)

Country Link
US (2) US7629382B2 (https=)
EP (1) EP1694313A4 (https=)
JP (1) JP2007514732A (https=)
AU (1) AU2004304716B2 (https=)
CA (1) CA2550459C (https=)
IL (1) IL176333A0 (https=)
WO (1) WO2005060341A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005060341A2 (en) 2003-12-18 2005-07-07 Biomas, Ltd Tellurium derivatives for prevention and treatment of neurodegenerative processes
US20080260770A1 (en) * 2004-09-17 2008-10-23 Biomas Ltd. Use of Tellurium Compounds as Adjuvants
ES2614113T3 (es) * 2004-09-17 2017-05-29 Biomas Ltd. Uso de tricloro (dioxietilen-O,O’) telurato de amonio (AS101) para la inhibición de la enzima convertidora de interleucina-1 beta
WO2008032227A2 (en) 2006-09-11 2008-03-20 Biomas, Ltd. Topical formulations of tellurium-containing compounds
SI2826371T1 (sl) * 2007-11-23 2019-09-30 Feramda Ltd. Metode in sestavki za inhibiranje integrinov z uporabo spojin, ki vsebujejo telur
US20100321208A1 (en) * 2009-06-23 2010-12-23 Craig Stephen Etchegoyen System and Method for Emergency Communications

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3369550A (en) 1967-02-17 1968-02-20 Thomas A. Armao Cryogenic clamps
GB1427415A (en) 1973-09-21 1976-03-10 Armao T A Cryosurgical instruments
US4761490A (en) * 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US5102908A (en) 1985-03-15 1992-04-07 Michael Albeck Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives
US4962207A (en) 1985-09-30 1990-10-09 Bar-Ilan University Organic derivatives of tellurium and selenium
US4752614A (en) 1985-09-30 1988-06-21 Bar-Ilan University Pharmaceutical compositions of tellerium and selenium compounds for the induction of in vivo and in vitro production of cytokines
US5093135A (en) 1985-09-30 1992-03-03 Michael Albeck Compounds for the induction of in vivo and in vitro production of cytokines
US4929739A (en) 1988-03-24 1990-05-29 Bar-Ilan University Complexes of tellurium and selenium derivatives
DE4007473A1 (de) 1990-03-09 1991-09-12 Tomsk G Med I Kryoskalpell
US5271925A (en) 1990-03-09 1993-12-21 Benjamin Sredni Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound
SE9200502D0 (sv) * 1992-02-20 1992-02-20 Astra Ab Novel antioxidants
US5262149A (en) * 1992-08-13 1993-11-16 Benjamin Sredni Method of treating or preventing alopecia
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
CN1156962A (zh) * 1994-09-01 1997-08-13 法玛西雅厄普约翰公司 替瑞拉得的助溶性胃肠外给药的制剂
US5576347A (en) 1994-11-14 1996-11-19 Sredni; Benjamin Method of treating gastric ulcers
ATE306927T1 (de) 1994-12-15 2005-11-15 Baker Norton Pharma Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
US5654328A (en) * 1994-12-15 1997-08-05 Sredni; Benjamin Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
US6428534B1 (en) 1999-02-24 2002-08-06 Cryovascular Systems, Inc. Cryogenic angioplasty catheter
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
AU2001218024A1 (en) 2000-06-19 2002-01-02 University Of Southern California Methods for treating and preventing alopecia
US20030148970A1 (en) 2001-01-12 2003-08-07 Besterman Jeffrey M. Methods for specifically inhibiting histone deacetylase-4
US6472381B1 (en) 2001-10-12 2002-10-29 Biomas Inc. Method of treating psoriasis
IL146694A (en) * 2001-11-22 2010-12-30 Biomas Ltd Use of an aqueous solution containing a biologically active complex of tellurium dioxide for manufacturing a medicament
CA2530634A1 (en) * 2003-06-12 2004-12-23 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium and selenium compounds
WO2005060341A2 (en) 2003-12-18 2005-07-07 Biomas, Ltd Tellurium derivatives for prevention and treatment of neurodegenerative processes
ES2614113T3 (es) 2004-09-17 2017-05-29 Biomas Ltd. Uso de tricloro (dioxietilen-O,O’) telurato de amonio (AS101) para la inhibición de la enzima convertidora de interleucina-1 beta
US20080260770A1 (en) 2004-09-17 2008-10-23 Biomas Ltd. Use of Tellurium Compounds as Adjuvants

Similar Documents

Publication Publication Date Title
JP2006523216A5 (https=)
JP2007517807A5 (https=)
JP2013540114A5 (https=)
JP2014518546A5 (https=)
JP2009504748A5 (https=)
JP2004534850A5 (https=)
JP2006509749A5 (https=)
JP2004516314A5 (https=)
JP2006500370A5 (https=)
JP2019537570A5 (https=)
JP2005506352A5 (https=)
DE602005004286D1 (de) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyridoä2,3-düpyrimidinderivate und verwandte verbindungen zur behandlung von krebs
JP2020507589A5 (https=)
TW200607807A (en) Macrocyclic beta-secretase inhibitors
JP2006507220A5 (https=)
JP2016534063A5 (https=)
JP2006515866A5 (https=)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
EP2228064A3 (en) Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
JP2013514980A5 (https=)
JP2011505356A5 (https=)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2008517913A5 (https=)
JP2010505865A5 (https=)
JP2008513510A5 (https=)